MedPath

Boron neutron capture therapy combined with X-ray fractionation and temozolomide for newly-diagnosed malignant glioma

Not Applicable
Recruiting
Conditions
malignant glioma
Registration Number
JPRN-UMIN000003984
Lead Sponsor
Department of Neurosurgery,Graduate School of Comprehensive Human Science, University of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)Dissemination 2)blood analyses AST,ALT > 100IU/ml , Bilirubin > 2.0mg% BUN > 30mg/dl , Cr > 1.8mg% WBC < 2500/mm3 , Plt < 75000/mm3 , Hb < 8g/dl 3)prior radiation 4)double cancer 5)phenylketonuria 6)considerable complications 7)other important condition which is inappropriater for the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath